Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) With LAP Protector

Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) With Rigid Spreading Versus Soft Spreading (Using LAP Protector)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01104233

Enrollment

Registered

2010-04-15

Start date

2010-03-31

Completion date

2010-12-31

Last updated

2010-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Video-assisted Thoracoscopic Surgery, Soft spreading, LAP Protector

Brief summary

The purpose of this study is to see if different types of spreading (rigid or soft) of Video-assisted Thoracoscopic Surgery (VATS) for lung cancer have different effects on pain.

Detailed description

The Lap-Protector (Hakko Co., Japan) is a device that consists of two flexible rings made of superelasticity alloys covered with polyurethane polyamide, and a thin silicone rubber membrane that is attached to the outer rim of the two rings. If the two rings are pulled apart, the device assumes a cylindrical shape. The outer diameter of each flexible ring is 12 cm, and this device can be used for minilaparotomy wounds between 5 and 9cm long.

Interventions

DEVICELAP Protector

The LAP Protector is a device that consists of two flexible rings made of superelasticity alloys covered with polyurethane polyamide, and a thin silicone rubber membrane that is attached to the outer rim of the two rings

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Non-small cell lung cancer stage IB - IIIA * ECOG status 0-1

Exclusion criteria

* Prior chemotherapy and/or radiation therapy for lung cancer * Peripheral neuropathy \> grade 1 * Concurrent other malignancies, other than basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix * Medical condition that will not permit treatment or follow up according to the protocol * Pregnant or nursing women * HIV-positive patients

Design outcomes

Primary

Measure	Time frame	Description
Compare the level of postoperative pain between the rigid and soft spreading groups	1 day	The level of postoperative pain was measured by Visual Analogue Scale (VAS).

Secondary

Measure	Time frame	Description
Compare early postoperative analgesic requirements between the rigid and soft spreading groups	1 week	Postoperative analgesic requirements (e.g. the amount of morphine titration).

Countries

China

Contacts

Primary ContactXin Xu, MD

yichunrenjia@126.com+86-20-83337792

Backup ContactWenlong Shao, MD

myfriends2003@126.com+86-20-83337792

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026